| Cited in | International search | Type: | Non-patent literature | Publication information: | [A] C. GIEFFERS ET AL: "APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc Receptors", MOLECULAR CANCER THERAPEUTICS, vol. 12, no. 12, 1 December 2013 (2013-12-01), pages 2735 - 2747, XP055197700, ISSN: 1535-7163, DOI: 10.1158/1535-7163.MCT-13-0323 | DOI: | http://dx.doi.org/10.1158/1535-7163.MCT-13-0323 | Type: | Non-patent literature | Publication information: | [A] PAMELA M. HOLLAND: "Death receptor agonist therapies for cancer, which is the right TRAIL?", CYTOKINE & GROWTH FACTOR REVIEWS, vol. 25, no. 2, 1 April 2014 (2014-04-01), pages 185 - 193, XP055204260, ISSN: 1359-6101, DOI: 10.1016/j.cytogfr.2013.12.009 | DOI: | http://dx.doi.org/10.1016/j.cytogfr.2013.12.009 | Type: | Non-patent literature | Publication information: | [A] H. WANG ET AL: "Immunoglobulin Fc Domain Fusion to TRAIL Significantly Prolongs Its Plasma Half-Life and Enhances Its Antitumor Activity", MOLECULAR CANCER THERAPEUTICS, vol. 13, no. 3, 15 January 2014 (2014-01-15), pages 643 - 650, XP055204262, ISSN: 1535-7163, DOI: 10.1158/1535-7163.MCT-13-0645 | DOI: | http://dx.doi.org/10.1158/1535-7163.MCT-13-0645 | Type: | Non-patent literature | Publication information: | [AP] J LEMKE ET AL: "Getting TRAIL back on track for cancer therapy", CELL DEATH AND DIFFERENTIATION, vol. 21, no. 9, 1 September 2014 (2014-09-01), pages 1350 - 1364, XP055145093, ISSN: 1350-9047, DOI: 10.1038/cdd.2014.81 | DOI: | http://dx.doi.org/10.1038/cdd.2014.81 | Cited in | Examination | Type: | Patent literature | Publication No.: | WO2014013037
| Type: | Patent literature | Publication No.: | US2004120955
| Type: | Patent literature | Publication No.: | US2011033521
| Type: | Patent literature | Publication No.: | WO2011076781
| Type: | Patent literature | Publication No.: | US2013079280
| Type: | Patent literature | Publication No.: | US7271149
| Type: | Non-patent literature | Publication information: | GIEFFERS CHRISTIAN ET AL: "APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc gamma Receptors", December 2013, MOLECULAR CANCER THERAPEUTICS, VOL. 12, NR. 12, PAGE(S) 2735-2747, ISSN: 1535-7163(print) * Supplementary Materials * | Type: | Non-patent literature | Publication information: | KLHN PC ET AL.: "IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA.", MABS, vol. 5, no. 2, 1 March 2013 (2013-03-01), pages 178 - 201, XP055137110, DOI: doi:10.4161/mabs.23655 | DOI: | http://dx.doi.org/10.4161/mabs.23655 | Type: | Non-patent literature | Publication information: | KLINQUER-HAMOUR C ET AL.: "World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA.", MABS, vol. 6, no. 1, 1 January 2014 (2014-01-01), pages 18 - 29, XP002760209, DOI: doi:10.4161/mabs.27437 | DOI: | http://dx.doi.org/10.4161/mabs.27437 | Type: | Non-patent literature | Publication information: | FATHIMUNISA BEGUM: "Immunology", 31 October 2014, PHI LEARNING, Delhi/India, pages: 86 [P] | Cited in | by applicant | Type: | Non-patent literature | Publication information: | SCHNEIDER ET AL., J EXP MED, vol. 187, 1989, pages 1205 - 1213 | Type: | Non-patent literature | Publication information: | SHIRAISHI ET AL., BIOCHEM BIOPHYS RES COMMUN, vol. 322, 2004, pages 197 - 202 | Type: | Non-patent literature | Publication information: | PAPADOPOULOS ET AL., CANCER CHEMOTHER PHARMACOL, 2015 | Type: | Non-patent literature | Publication information: | VAN DER SLOOT ET AL., PNAS, vol. 103, 2006, pages 8634 - 8639 | Type: | Non-patent literature | Publication information: | KELLEY ET AL., J. BIOL. CHEM., vol. 280, 2005, pages 2205 - 2215 | Type: | Non-patent literature | Publication information: | MACFARLANE ET AL., CANCER RES., vol. 65, 2005, pages 11265 - 11270 | Type: | Non-patent literature | Publication information: | LIU ET AL., J. BIOL. CHEM., vol. 286, 2011, pages 11211 - 11217 | Type: | Non-patent literature | Publication information: | SAMBROOK ET AL.: "Molecular Cloning, A Laboratory Manual", 1989, COLD SPRING HARBOR PRESS [A] 1-22 * abstract * * page 2736 * * figure 1A * | Type: | Non-patent literature | Publication information: | AUSUBEL ET AL.: "Current Protocols in Molecular Biology", 1989, JOHN WILEY & SONS [A] 1-22 * the whole document * | Type: | Non-patent literature | Publication information: | WONG ET AL., MOL. CANCER THER., vol. 11, 2012, pages 1026 - 1035 [A] 1-22 * abstract * * figure 1A * | Type: | Non-patent literature | Publication information: | BERNEBAUM, ADV. CANCER RES., vol. 35, 1981, pages 269 - 335 | Type: | Non-patent literature | Publication information: | BORISY ET AL., PROC. NATL. ACAD. SCI. USA, vol. 100, 2003, pages 7977 - 7982 [AP] 1-22 * the whole document * | Cited in | other | Type: | Non-patent literature | Publication information: | GIEFFERS C; KLUGE M; ET AL.,: "APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc Receptors", MOLECULAR CANCER THERAPEUTICS,, vol. 12, December 2013 (2013-12-01), pages 2735 - 2747, XP055197700, Retrieved from the Internet | DOI: | http://dx.doi.org/10.1158/1535-7163.MCT-13-0323 | Type: | Non-patent literature | Publication information: | GIEFFERS C; KLUGE M; ET AL.,: "APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc Receptors (Supplementary Material)", MOLECULAR CANCER THERAPEUTICS, 7 October 2013 (2013-10-07), pages 1 - 18, XP055392672 | Type: | Non-patent literature | Publication information: | FATHIMUNISA BEGUM: "Immunology", 2014, PHI LEARNING PRIVATE LIMETED, pages: 2pp, 86, XP055392699 | Type: | Non-patent literature | Publication information: | PETER-CHRISTIAN KLHN; ET AL.,: "IBC's 23nd Annual Antibody Engineering, 10th Annual Antibody Therapeutics International Conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA", MABS, vol. 5, no. 2, March 2013 (2013-03-01), pages 178 - 201, XP055070468 | DOI: | http://dx.doi.org/10.4161/mabs.23655 | Type: | Non-patent literature | Publication information: | CHRISTINE KLINGUER-HAMOUR; PAVEL STROP; DHAVAL K SHAH; LAURENT DUCRY; APRIL XU; ALAIN BECK: "World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA", MABS,, vol. 6, no. 1, January 2014 (2014-01-01), pages 18 - 29, XP002760209 | DOI: | http://dx.doi.org/10.4161/mabs.27437 |
